Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies

Abstract

Severe Acute Respiratory human Coronavirus 2 (SARS-hCOV 2) infection which began in December 2019 has rapidly disseminated worldwide due to non-availability of anti-viral treatment or vaccine, no knowledge of virus-human interaction, lack of prognostic factors for stages of illness and ability of hCoV 2 to rapidly mutate and infect multiple cell types. Host inflammation and evasion of host immune responses by viruses are believed to play major roles in disease severity of human Corona viruses (hCoVs), thus uses of anti-inflammatory and immune-boosting agents apart from complete multi-disciplinary approach are suggested to combat the ranvaging SAR-hCOV 2 infection. This paper related the structural proteins and life cycle of CoV with host immune responses to CoV. This is to bring out gaps in knowledge for possible future researches

Click to view file (PDF)

References

Abraham S, Kienzle TE, Lapps W, Brian DA. (1990). Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology 176(1):296–301.

Arinola OG, Oluwafemi Oluwole, Regina Oladokun, Babatunde O Adedokun, Olufunmilayo I Olopade, Christopher O Olopade. (2014). Intestinal helminthic infection increases serum levels of IL-2 and decreases serum TGF-beta levels in Nigerian asthmatic patients. Open Journal of Immunology. Open Journal of Immunology. 4, 1-8.

Arinola OG. (2003). Cells of the Immune System, Chapter 6 in Basic Immunology for Students of Medicine and Biology. ISBN: 9782194328 Edited by L.S. Salimonu, College Press, Nigeria. pp: 48-55.

Baranov PV, Henderson CM, Anderson CB, Gesteland RF, Atkins JF, Howard MT. (2005). Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology. 332(2):498–510.

Belouzard S, Chu VC, Whittaker GR. (2009). Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proceedings of the National Academy of Sciences of the United States of America. 106(14):5871–5876.

Beniac DR, Andonov A, Grudeski E, Booth TF. (2006). Architecture of the SARS coronavirus prefusion spike. Nature Structural & Molecular Biology. 13(8):751–752.

Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. (2003). The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology. 77(16): 8801–8811.

Cardone M, Ikeda KN, Varano B, Gessani S, Conti L. (2015). HIV‐1‐induced impairment of dendritic cell cross talk with gammadelta T lymphocytes. J Virol. 89(9): 4798‐ 4808.

Cecere TE, Todd SM, Leroith T. (2012). Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses 4(5): 833‐ 846.

Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ, Chang WL, Lin CH, Huang TH. (2006). Modular organization of SARS coronavirus nucleocapsid protein. Journal of biomedical science. 13(1): 59–72.

Channappanavar R et al. (2016). Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 19(2):181–193

Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S. (2014). Virus‐specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 88(19): 11034‐ 11044.

Chen J, Lau YF, Lamirande EW, et al. (2010). Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS‐CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS‐CoV infection. J Virol. 84(3): 1289‐ 1301.

Cheung CY et al. (2005). Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79(12):7819–7826

Coronavirus impacts education. UNESCO. 4 March 2020. Retrieved 7 March 2020.

Coronavirus: Poland to close borders to foreigners, quarantine returnees. Reuters. 14 March 2020. Retrieved 13 March 2020 – via The Straits Times.

de Haan CA, Rottier PJ. (2005). Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 64:165–230.

Drosten C et al. (2013). Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 13(9):745–751

Edem V.F and Arinola O.G (2015). Leucocyte migration and intracellular killing in newly diagnosed pulmonary tuberculosis patients and during anti-tuberculosis chemotherapy. Annals of Global Health. 81(5): 669-674.

Fairman P, Angel JB. (2012). The effect of human immunodeficiency virus‐1 on monocyte‐derived dendritic cell maturation and function. Clin Exp Immunol. 170(1): 101‐ 113.

Fehr AR and Perlman S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods Mol Biol. 1282: 1–23. doi: 10.1007/978-1-4939-2438-7_1.

Fung TS and Ding X. (2014). Coronavirus infection, ER stress, apoptosis and innate immunity. Front. Microbiol. | https://doi.org/10.3389/fmicb.2014.00296

Gralinski LE, Sheahan TP, Morrison TE, et al. (2018). Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio. 9(5):e01753.

Guo Y, Xu WW, Song J, Deng W, Liu DQ, Zhang HT.(2012). Intracellular overexpression of HIV‐1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells. PLOS One. 7(7):e40179

Hamming, I. et al. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631–637.

Houser KV, Gretebeck L, Ying T, et al. (2016). Prophylaxis with a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV Infection. J Infect Dis. 213(10):1557‐1561.

Jiang Y et al. (2005). Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 171(8):850–857

Krijnse-Locker J, Ericsson M, Rottier PJM, Griffiths G. (1994). Characterization of the budding compartment of mouse hepatitis virus: Evidence that transport from the RER to the golgi complex requires only one vesicular transport step. J Cell Biol. 124:55–70.

Li G, Fan Y, Lai Y. Han T, Li Z, Pan P, Wang W et al. (2020). Coronavirus infections and immune responses. J. Med. Vir. 2020. https://doi.org/10.1002/jmv.25685

Li, W. et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454.

Maloir Q, Ghysen K, von Frenckell C, Louis R, Guiot J. (2018). Acute respiratory distress revealing antisynthetase syndrome]. Rev Med Liege. 73(7‐8): 370‐ 375.

Molenkamp R, Spaan WJ. (1997). Identification of a specific interaction between the coronavirus mouse hepatitis virus A59 nucleocapsid protein and packaging signal. Virology. 239(1):78–86.

Ng OW, Chia A, Tan AT, et al. (2016). Memory T cell responses targeting the SARS coronavirus persist up to 11 years post‐infection. Vaccine. 34(17): 2008‐ 2014.

Niu P, Zhang S, Zhou P, et al. (2018). Ultrapotent human neutralizing antibody repertoires against Middle East Respiratory syndrome coronavirus from a recovered patient. J Infect Dis. 218(8):1249-1260.

Niu P, Zhao G, Deng Y, et al. (2018). A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice. Science China Life sciences. 61(10):1280-1282.

Olaniyi JA and Arinola OG. (2011). Humoral immunoglobulin factors and nitric oxide levels in HIV patients with low CD4+ T-lymphocyte count. Intl. J of Health Research. 4(2). 67-74.

Peiris JS et al. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 361(9371):1767–1772

Rodrigue-Gervais IG et al. (2014). Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe. 15(1):23–35

Schneider WM, Chevillotte MD, Rice CM. (2014). Interferon‐stimulated genes: a complex web of host defenses. Annu Rev Immunol. 32: 513‐ 545.

Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. (2003). Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 331:991–1004.

Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, Tong SYC, Lewin SR & Kedzierska K. (2020). Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nature Medicine 26: 453–455.

Ural BB, Yeung ST, Payal Damani-Yokota P, Devlin JC, Maren de Vries, Vera-Licona P, Tasleem Samji, Catherine M. Sawai, Geunhyo Jang, Perez OA, Pham Q, Maher L, P'ng Loke, Dittmann M, Reizis B and Kamal M. Khanna KM. (2020). Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties. Science Immunology. 5, Issue 45, eaax8756

van den Brand JM et al. (2014). The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 2014. 151(1):83–112

WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020. World Health Organization. 11 March 2020. Retrieved 11 March 2020.

Wu L, Wang N, Chang Y, Tian X, Na D, Zhang L, Zheng L, Lan T, Wang L and Liang G. (2007). Duration of Antibody Responses after Severe Acute Respiratory Syndrome. Emerg Infect Dis. 13(10): 1562–1564.

Wu L, Wang N, Chang Y, Tian X, Na D, Zhang L, Zheng L, Lan T, Wang L and Liang G. (2007). Duration of Antibody Responses after Severe Acute Respiratory Syndrome. Emerg Infect Dis. 13(10): 1562–1564.

Ying T, Du L, Ju TW, et al. (2014). Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 88(14):7796-7805.

Zhao J et al. (2010). T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol. 84(18):9318–9325.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array